Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sleep onset latency, next day; · Shift workers
1 finding from 1 review
Sleep efficiency · Shift workers
1 finding from 1 review
Sleepiness during the night shift, postintervention; · Shift workers
1 finding from 1 review
Total sleep time, next day Diaries and actigraphy. Scale from: 120 to 600. · Shift workers
1 finding from 1 review
Sleepiness during the day shift · Shift workers
1 finding from 1 review
Total sleep time, next night; · Shift workers
1 finding from 1 review
Sleep onset latency, next night; · Shift workers
1 finding from 1 review
Sleep efficiency · Shift workers
1 finding from 1 review
Complications
It is very uncertain whether amino acid solution, alone or in combination with dextrose changes complications compared with dextrose solution (very low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
All‐cause mortality
It is very uncertain whether amino acid solution, alone or in combination with dextrose changes mortality compared with dextrose solution (very low certainty).
1 finding from 1 review
Death · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse Number of participants having recurrence after stopping · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
End‐of‐treatment response · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sustained virological response · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · patients on HD with HCV infection
Standard interferon plus ribavirin may leads to higher treatment discontinuation compared with standard interferon alone (low certainty).
1 finding from 1 review
Adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse Number of participants having recurrence after stopping · patients on HD with HCV infection
Pegylated interferon plus ribavirin may leads to lower relapse(recurrence after stopping) compared with pegylated interferon alone (low certainty).
1 finding from 1 review